Previous studies showed that ACE2 and CD209 were overexpressed in the healthy lungs of smokers, especially former smokers (Cai et al., 2020a; Cai et al., 2020b), but the relevance of this phenomenon in lung cancer remains unclear. Here, ACE2 is linked to lung cancer.